Steve Beuchaw
Stock Analyst at Morgan Stanley
(2.42)
# 2,408
Out of 5,172 analysts
98
Total ratings
58.46%
Success rate
6.33%
Average return
Main Sectors:
Stocks Rated by Steve Beuchaw
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Downgrades: Equal-Weight | $49 → $47 | $39.93 | +17.93% | 2 | Jan 6, 2025 | |
| A Agilent Technologies | Initiates: Outperform | n/a | $111.30 | - | 20 | Dec 13, 2023 | |
| ALGN Align Technology | Maintains: Outperform | $711 → $770 | $173.18 | +344.62% | 11 | Jul 29, 2021 | |
| BRKR Bruker | Upgrades: Peer Perform | n/a | $33.35 | - | 9 | Nov 16, 2020 | |
| HSIC Henry Schein | Upgrades: Outperform | $68 | $72.29 | -5.93% | 4 | Apr 2, 2020 | |
| XRAY DENTSPLY SIRONA | Upgrades: Outperform | $66 | $10.95 | +502.74% | 6 | Apr 2, 2020 | |
| ILMN Illumina | Maintains: Equal-Weight | $320 → $288 | $124.33 | +131.64% | 9 | Jan 7, 2019 | |
| TMO Thermo Fisher Scientific | Maintains: Overweight | $254 → $260 | $474.39 | -45.19% | 7 | Oct 25, 2018 | |
| WAT Waters | Maintains: Equal-Weight | $204 → $211 | $298.99 | -29.43% | 13 | Oct 10, 2018 | |
| MYGN Myriad Genetics | Maintains: Overweight | $51 → $54 | $4.58 | +1,079.04% | 10 | Oct 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $21 → $41 | $195.28 | -79.00% | 5 | Sep 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $335 | $264.49 | +26.66% | 1 | Sep 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $335 | $268.55 | +24.74% | 1 | Sep 20, 2018 |
Qiagen
Jan 6, 2025
Downgrades: Equal-Weight
Price Target: $49 → $47
Current: $39.93
Upside: +17.93%
Agilent Technologies
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $111.30
Upside: -
Align Technology
Jul 29, 2021
Maintains: Outperform
Price Target: $711 → $770
Current: $173.18
Upside: +344.62%
Bruker
Nov 16, 2020
Upgrades: Peer Perform
Price Target: n/a
Current: $33.35
Upside: -
Henry Schein
Apr 2, 2020
Upgrades: Outperform
Price Target: $68
Current: $72.29
Upside: -5.93%
DENTSPLY SIRONA
Apr 2, 2020
Upgrades: Outperform
Price Target: $66
Current: $10.95
Upside: +502.74%
Illumina
Jan 7, 2019
Maintains: Equal-Weight
Price Target: $320 → $288
Current: $124.33
Upside: +131.64%
Thermo Fisher Scientific
Oct 25, 2018
Maintains: Overweight
Price Target: $254 → $260
Current: $474.39
Upside: -45.19%
Waters
Oct 10, 2018
Maintains: Equal-Weight
Price Target: $204 → $211
Current: $298.99
Upside: -29.43%
Myriad Genetics
Oct 10, 2018
Maintains: Overweight
Price Target: $51 → $54
Current: $4.58
Upside: +1,079.04%
Sep 28, 2018
Maintains: Overweight
Price Target: $21 → $41
Current: $195.28
Upside: -79.00%
Sep 20, 2018
Initiates: Equal-Weight
Price Target: $335
Current: $264.49
Upside: +26.66%
Sep 20, 2018
Initiates: Equal-Weight
Price Target: $335
Current: $268.55
Upside: +24.74%